← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-965 | 69374-965-02 | Diazepam | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:526 | 526 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5570 | 26436-5570-3 | Estriol; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:526 | 526 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-500 | 70092-500-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:526 | 526 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:526 | 526 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:526 | 526 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6527 | 72934-6527-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:526 | 526 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:527 | 527 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5373 | 26436-5373-3 | Estriol; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-502 | 65302-502-03 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-3 | Glutathione | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5028 | 26436-5028-3 | Glutathione | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:527 | 527 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:527 | 527 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:528 | 528 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-103 | 69761-103-01 | Testosterone | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:528 | 528 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diazepam Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:528 | 528 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:528 | 528 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5513 | 26436-5513-3 | Estriol; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-502 | 65302-502-05 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:528 | 528 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4520 | 72682-4520-1 | Glutathione | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-216 | 70092-216-50 | Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:528 | 528 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:529 | 529 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6074 | 71285-6074-1 | Vancomycin 1.25gm added to NS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6573 | 71300-6573-1 | Diclofenac Sodium | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:529 | 529 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:529 | 529 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0929 | 26436-0929-1 | Estriol; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:529 | 529 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1014 | 70657-1014-3 | Glutathione | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:529 | 529 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-1 | Glutathione | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-217 | 70092-217-47 | Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:529 | 529 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:529 | 529 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:530 | 530 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6007 | 72196-6007-1 | Phenylephrine 40mcg/ml in NS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-3 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5563 | 26436-5563-3 | Estriol; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-15 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-083 | 70092-083-44 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4520 | 72682-4520-1 | Glutathione | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-072 | 71449-072-41 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione; Ascorbic Acid; Zinc Sulfate Heptahydrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:530 | 530 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:530 | 530 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-30 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:531 | 531 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:531 | 531 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:531 | 531 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:531 | 531 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5522 | 26436-5522-1 | Estriol; Testosterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-32 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-072 | 71449-072-82 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:531 | 531 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:531 | 531 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:531 | 531 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-05 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:532 | 532 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-029 | 71506-029-58 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:532 | 532 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:532 | 532 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:532 | 532 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-3 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0375 | 26436-0375-3 | Estriol; Testosterone; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-02 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-104 | 73198-104-30 | Glutathione; Ascorbic Acid; Zinc Sulfate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:532 | 532 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:532 | 532 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:532 | 532 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-28 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:533 | 533 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:533 | 533 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:533 | 533 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-202 | 70004-202-22 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5552 | 26436-5552-3 | Estriol; Testosterone; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-01 | Fentanyl | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-103 | 73198-103-10 | Glycerin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-180 | 70092-180-79 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5227 | 26436-5227-3 | Glycine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:533 | 533 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:534 | 534 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9225 | 71266-9225-1 | Fentanyl and Bupivacaine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:534 | 534 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:534 | 534 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5524 | 26436-5524-3 | Estriol; Testosterone; Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-05 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:534 | 534 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:534 | 534 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:534 | 534 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:535 | 535 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-335 | 70092-335-76 | Ropivacaine PF 0.2% 250ml CADD-Y FSFF | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:535 | 535 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:535 | 535 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-32 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5546 | 26436-5546-1 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8610 | 71266-8610-1 | Glycerin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:535 | 535 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-05 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:535 | 535 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0432 | 72196-0432-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:535 | 535 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:536 | 536 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5537 | 72934-5537-4 | Nobela | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:536 | 536 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-04 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-16 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5568 | 26436-5568-3 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-100 | 73198-100-10 | Glycerin; Epinephrine; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:536 | 536 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-2 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:536 | 536 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:537 | 537 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0010 | 70168-0010-1 | Testo12.5mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:537 | 537 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-09 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-32 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-17 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5502 | 26436-5502-3 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-134 | 73198-134-10 | Glycerin; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-2 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6528 | 72934-6528-2 | Hydrocortisone; Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:537 | 537 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:537 | 537 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:538 | 538 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8107 | 70168-8107-1 | Testosterone 100mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:538 | 538 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-30 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-40 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5565 | 26436-5565-3 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1006 | 73013-1006-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2022-2 | valid | 0 | 2026-10-15 |